Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares RepurchasedShort-Term Debt repayments
Ratios

Bruker (BRKR) EBIAT (2016 - 2025)

Bruker (BRKR) has disclosed EBIAT for 16 consecutive years, with $26.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIAT rose 82.64% year-over-year to $26.3 million, compared with a TTM value of -$29.8 million through Dec 2025, down 126.19%, and an annual FY2025 reading of -$8.3 million, down 107.29% over the prior year.
  • EBIAT was $26.3 million for Q4 2025 at Bruker, up from -$71.8 million in the prior quarter.
  • Across five years, EBIAT topped out at $203.3 million in Q4 2023 and bottomed at -$71.8 million in Q3 2025.
  • Average EBIAT over 5 years is $54.5 million, with a median of $56.9 million recorded in 2021.
  • The sharpest move saw EBIAT surged 440.0% in 2021, then crashed 275.55% in 2025.
  • Year by year, EBIAT stood at $78.2 million in 2021, then grew by 26.98% to $99.3 million in 2022, then skyrocketed by 104.73% to $203.3 million in 2023, then plummeted by 92.92% to $14.4 million in 2024, then soared by 82.64% to $26.3 million in 2025.
  • Business Quant data shows EBIAT for BRKR at $26.3 million in Q4 2025, -$71.8 million in Q3 2025, and -$1.1 million in Q2 2025.